Genetic Counseling: Step-by-Step Guide on How to Write SOAP Notes

Written by SOAPNoteAI Editorial Team · Updated June 2026

Genetic counseling documentation is unlike documentation in any other discipline. The encounter is part risk-assessment, part laboratory science, part shared decision-making, and part psychosocial support, and the note must reflect all four. A well-written genetic counseling SOAP note captures a detailed multi-generation family history, a quantitative risk assessment, a rigorously documented informed consent discussion, precise variant results, and the patient's emotional response to information that can affect not only their own health but the health of their relatives.

This guide provides comprehensive instructions for documenting genetic counseling encounters across hereditary cancer, prenatal, cardiovascular, pediatric, and adult-onset genetics contexts. Whether you are constructing a three-generation pedigree, obtaining consent for a multi-gene panel, disclosing a BRCA result, or explaining a variant of uncertain significance, mastering genetic-counseling-specific documentation supports accurate risk communication, defensible consent records, and continuity of care across the family.

Create Your Genetic Counseling SOAP Note in 2 Minutes

Start with 20 free SOAP notes. No credit card required.

Try Free on Web

What Makes Genetic Counseling Documentation Unique

Genetic counseling differs from other specialties in several fundamental documentation aspects:

The Pedigree Is the Core Objective Finding: A standardized three-generation pedigree is the central data element, comparable to a physical exam in other specialties, and must be captured with structured nomenclature.
Consent Documentation Is Paramount: Genetic testing carries implications for biological relatives, insurance, and reproduction. The informed consent discussion is the most legally and ethically significant part of the note.
Variant Precision Is Non-Negotiable: Gene names, HGVS variant nomenclature, zygosity, and ACMG classification must be exact and transcribed from the official laboratory report, never paraphrased.
Quantitative Risk Assessment: Notes must document numeric recurrence and carrier risks, the inheritance model applied, and the source of population estimates.
Psychosocial Assessment Is Clinical, Not Optional: The patient's emotional state, coping resources, and decisional readiness are billable, medically necessary components that shape the entire encounter.
Family-Centered Scope: Recommendations frequently extend to at-risk relatives through cascade testing, making the at-risk family a documented part of the plan.

Subjective Section (S)

In a genetic counseling SOAP note, the Subjective section captures the reason for referral, the patient's understanding and expectations, the detailed family and reproductive history, and the psychosocial context. This section frames the entire risk assessment and counseling approach.

Subjective Section (S) Components

Reason for Referral / Chief Concern:
- Why the patient was referred and by whom, and what the patient hopes to learn
- Example: "Referred by oncology for evaluation of hereditary breast and ovarian cancer risk following a personal diagnosis of breast cancer at age 38."
Patient's Understanding and Expectations:
- What the patient already knows about the condition or testing and what they expect from the visit
- Example: "Patient understands her sister tested positive for a BRCA1 pathogenic variant and wishes to learn whether she carries the same variant."
Personal Medical History:
- Relevant diagnoses with age at diagnosis, prior genetic testing, surgeries, and reproductive history
- Example: "Personal history of left-sided invasive ductal carcinoma diagnosed at age 38, treated with lumpectomy and chemotherapy. No prior genetic testing."
Detailed Family History (Pedigree Narrative):
- Three generations: proband, first-degree relatives (parents, siblings, children), and second-degree relatives (grandparents, aunts, uncles)
- Ages and health status of living relatives; cause and age of death for deceased relatives
- Specific diagnoses with age at diagnosis, particularly cancers, congenital anomalies, intellectual disability, sudden cardiac death, and known genetic conditions
- Consanguinity and ancestry/ethnicity (relevant to founder mutations and carrier frequencies)
- Example: "Maternal aunt with ovarian cancer at age 52; maternal grandmother with breast cancer at age 60; sister with BRCA1 pathogenic variant. Ashkenazi Jewish ancestry on maternal side. No reported consanguinity."
Reproductive History (when relevant):
- Pregnancies, live births, miscarriages, stillbirths, terminations, and any affected pregnancies
- Current pregnancy status and gestational age for prenatal cases
- Example: "Gravida 2, para 1, with one prior miscarriage at 10 weeks. Currently 12 weeks pregnant by LMP."
Information Source and Reliability:
- Who provided the family history and whether records were available to confirm key diagnoses
- Example: "Family history provided by patient; sister's genetic test result confirmed by laboratory report. Other relative diagnoses reported by patient and not independently confirmed."
Psychosocial History:
- Emotional state, coping resources, support system, prior experience with the condition, and decisional context
- Example: "Patient reports significant anxiety about her children's risk. Strong support from spouse. Witnessed her aunt's illness, which contributes to her sense of urgency."
Relevant Lifestyle and Environmental Factors (when relevant):
- Exposures, reproductive plans, and other modifiers of risk
- Example: "Patient is considering future pregnancy and asks about reproductive options if she is found to carry the familial variant."

Tips for Genetic Counseling Subjective Documentation:

Always document who provided the family history and which diagnoses are confirmed versus reported.
Record ancestry explicitly when it affects carrier frequency or founder-mutation risk.
Capture the patient's stated goals; they justify medical necessity and shape the counseling.
Document reproductive history precisely using gravida/para terminology when relevant.

Example of a Subjective Section for Genetic Counseling

Subjective

REASON FOR REFERRAL: A 38-year-old woman referred by oncology for hereditary cancer risk assessment following a personal diagnosis of breast cancer and a known familial BRCA1 pathogenic variant identified in her sister.

PATIENT'S UNDERSTANDING AND GOALS: The patient is aware that her sister carries a BRCA1 pathogenic variant. She seeks to determine whether she carries the same variant, to understand the implications for her own surveillance and surgical options, and to learn what testing would mean for her two children.

PERSONAL MEDICAL HISTORY: Left-sided invasive ductal carcinoma diagnosed at age 38, treated with lumpectomy, sentinel node biopsy, and adjuvant chemotherapy. No prior genetic testing. Menarche age 12, two term pregnancies, no oral contraceptive use beyond two years in her twenties.

FAMILY HISTORY (three-generation pedigree obtained):

- Sister, age 41: BRCA1 pathogenic variant confirmed by laboratory report; unaffected to date.

- Mother, age 66: living, no cancer history.

- Maternal aunt: ovarian cancer diagnosed at age 52, deceased at age 55.

- Maternal grandmother: breast cancer diagnosed at age 60, deceased at age 71 of unrelated causes.

- Father, age 68, and paternal relatives: no reported cancer history.

- Two children (son age 10, daughter age 8): healthy.

Ancestry: Ashkenazi Jewish on the maternal side. No reported consanguinity.

INFORMATION SOURCE: Family history provided by the patient. Sister's BRCA1 result confirmed by laboratory report supplied to the clinic. Other relative diagnoses are patient-reported and not independently confirmed by medical records.

PSYCHOSOCIAL HISTORY: The patient reports moderate anxiety, focused primarily on her children's potential risk. She has strong support from her spouse and describes good coping resources. She witnessed her maternal aunt's illness, which heightens her sense of urgency. She is considering future risk-reducing surgery and wishes to make an informed decision.

Objective Section (O)

The Objective section in genetic counseling captures the structured pedigree, any examination findings, prior and current test results, and the quantitative risk data that the counseling is built upon. Accuracy here is essential because downstream medical decisions depend on it.

Objective Section (O) Components

Three-Generation Pedigree (Structured):
- The formal pedigree using standardized nomenclature (NSGC / Bennett et al. recommendations)
- Generations represented, affected individuals, carrier status where known, and key ages
- Example: "Three-generation pedigree constructed and reviewed. See attached pedigree diagram. Pattern consistent with autosomal dominant transmission of hereditary breast and ovarian cancer."
Relevant Physical / Dysmorphology Examination (when performed):
- For syndromic evaluations, document measured findings such as growth parameters and specific dysmorphic features
- Example: "Targeted exam: occipitofrontal circumference at the 50th percentile; no dysmorphic features noted." (Document measured values; do not estimate.)
Prior Genetic Test Results:
- Previously completed testing in the patient or relatives, with gene, variant, classification, and laboratory
- Example: "Sister's result (laboratory report on file): BRCA1 c.5266dupC, heterozygous, classified Pathogenic."
Current / Ordered Test Results:
- Results transcribed verbatim from the official laboratory report: gene, HGVS variant nomenclature, zygosity, classification, methodology, and laboratory
- Example: "Targeted single-site analysis for BRCA1 c.5266dupC ordered; results pending."
Risk Quantification Data:
- Empiric or calculated risk figures with their source, and any risk model applied
- Example: "Tyrer-Cuzick model not applied given known familial pathogenic variant; risk assessment based on Mendelian inheritance."
Ancestry-Relevant Carrier Data (when applicable):
- Population carrier frequencies relevant to the patient's ancestry
- Example: "Ashkenazi Jewish ancestry: relevant to BRCA1/2 founder variant frequency; documented for context."
Records and Documentation Reviewed:
- Pathology reports, prior genetic reports, imaging, or external records reviewed during the encounter
- Example: "Reviewed: oncology pathology report, sister's genetic test report. Maternal aunt's pathology unavailable."

Pedigree Documentation Framework Template

Pedigree Documentation Template

PEDIGREE SUMMARY:

Generations documented: [Number, minimum three]

Proband: [Age, affected status, relevant diagnoses with age at diagnosis]

First-degree relatives: [Parents, siblings, children - ages, health status, diagnoses]

Second-degree relatives: [Grandparents, aunts, uncles - relevant diagnoses and ages]

Deceased relatives: [Cause and age of death]

Consanguinity: [Present / Absent / Unknown]

Ancestry/Ethnicity: [Relevant to carrier frequency and founder mutations]

Reproductive history: [Gravida/para, losses, affected pregnancies]

Information source: [Who reported; what was confirmed by records]

INHERITANCE PATTERN SUGGESTED: [Autosomal dominant / recessive / X-linked / mitochondrial / multifactorial / undetermined]

PRIOR TEST RESULTS (from laboratory reports):

Gene: [ ] Variant (HGVS): [ ] Zygosity: [ ] Classification: [P/LP/VUS/LB/B] Laboratory: [ ]

CURRENT/ORDERED TESTING:

Test ordered: [ ] Methodology: [ ] Status: [Pending/Resulted]

Example of an Objective Section for Genetic Counseling

Objective

PEDIGREE: Three-generation pedigree constructed and reviewed with the patient (see attached pedigree diagram). The pattern is consistent with autosomal dominant transmission of hereditary breast and ovarian cancer syndrome on the maternal line.

KEY FAMILY DATA POINTS:

- Proband: breast cancer at age 38.

- Sister: BRCA1 pathogenic variant carrier (confirmed by report), unaffected.

- Maternal aunt: ovarian cancer at age 52.

- Maternal grandmother: breast cancer at age 60.

ANCESTRY: Ashkenazi Jewish on the maternal side, relevant to BRCA1/2 founder variant frequency.

PRIOR GENETIC RESULTS (from laboratory report on file):

- Sister: BRCA1, c.5266dupC, heterozygous, classified Pathogenic. Testing laboratory and accession documented in the chart.

CURRENT TESTING:

- Targeted single-site analysis for the familial BRCA1 c.5266dupC variant ordered today via the same reference laboratory. Result status: pending.

RISK ASSESSMENT BASIS: Given a confirmed familial pathogenic variant, risk assessment is based on Mendelian inheritance rather than an empiric risk model. The patient has a 50% prior probability of carrying the familial variant.

RECORDS REVIEWED: Oncology pathology report and sister's genetic test report reviewed during the visit. Maternal aunt's pathology records were unavailable.

Assessment Section (A)

The Assessment section synthesizes the family history, examination, results, and psychosocial context into a clinical formulation: the working risk assessment, the inheritance model, the recurrence risk, and the psychosocial readiness that informs the plan.

Assessment Section (A) Components

Risk Assessment / Clinical Impression:
- The genetic counselor's formulation of the patient's risk and the most likely explanation
- Example: "Patient at 50% prior risk of carrying the familial BRCA1 pathogenic variant; personal breast cancer history at a young age is consistent with hereditary etiology."
Inheritance Pattern and Recurrence Risk:
- The inheritance model and the numeric recurrence or transmission risk with its basis
- Example: "Autosomal dominant inheritance. If the patient carries the familial variant, each of her children has a 50% risk of inheriting it."
Differential / Alternative Explanations (when relevant):
- Other genetic or non-genetic explanations considered
- Example: "Sporadic disease cannot be excluded until testing results return, though the family history strongly favors a hereditary etiology."
Variant Interpretation (when results are available):
- The ACMG classification and its clinical meaning, transcribed from the laboratory report
- Example: "Result, when available, will be interpreted per ACMG/AMP criteria; a pathogenic result would confirm hereditary breast and ovarian cancer syndrome."
Psychosocial Assessment:
- Emotional state, coping, risk perception accuracy, decisional readiness, and any psychological needs
- Example: "Patient demonstrates accurate risk perception and good coping resources; moderate anxiety focused on children's risk. Decisionally ready to proceed with testing."
Reproductive and Family Implications:
- Implications for at-risk relatives and for reproductive decisions
- Example: "Result will have direct implications for cascade testing of her two children once they reach an appropriate age, and for her sister's surveillance decisions."

Genetic Risk Assessment Approach

For systematic assessment, consider:

For Hereditary Cancer:

Personal and family pattern consistent with a syndrome
Known familial variant versus undiagnosed family
Surveillance and risk-reduction implications

For Prenatal / Reproductive Cases:

Carrier status of both partners
Inheritance model and per-pregnancy recurrence risk
Reproductive options and timing

For Cardiovascular / Pediatric Genetics:

Mode of inheritance and penetrance
Cascade screening of at-risk relatives
Phenotype-genotype correlation when known

Example of an Assessment Section for Genetic Counseling

Assessment

RISK ASSESSMENT / CLINICAL IMPRESSION:

A 38-year-old woman with early-onset breast cancer and a confirmed familial BRCA1 pathogenic variant on the maternal line. She carries a 50% prior probability of having inherited the familial variant. Her personal and family history is strongly consistent with hereditary breast and ovarian cancer (HBOC) syndrome.

INHERITANCE AND RECURRENCE RISK:

Autosomal dominant inheritance. If the patient is found to carry the familial BRCA1 c.5266dupC variant, each of her children has a 50% chance of inheriting it. Predictive testing in the children would be deferred until they reach an age of consent, as this is an adult-onset condition without childhood intervention.

VARIANT INTERPRETATION:

Targeted single-site testing for the known familial variant is pending. A positive result would confirm an HBOC-associated pathogenic variant per ACMG/AMP classification. A negative result for the specific familial variant would substantially reduce, though not entirely eliminate, her hereditary risk and would require interpretation in the context of her personal cancer history.

PSYCHOSOCIAL ASSESSMENT:

The patient demonstrates accurate risk perception and good coping resources, with moderate anxiety centered on her children's future risk. She is decisionally ready and has realistic expectations of testing. No acute psychological referral is indicated at this time.

FAMILY IMPLICATIONS:

A positive result would support cascade testing of at-risk relatives and would inform surveillance and risk-reducing surgical decisions for the patient.

Plan Section (P)

The Plan section documents the testing decision and consent, the surveillance and risk-reduction recommendations, the anticipatory guidance, cascade testing for relatives, referrals, and follow-up. In genetic counseling, the informed consent record and the at-risk family plan are the most important elements.

Plan Section (P) Components

Genetic Testing Plan and Informed Consent:
- Test ordered, laboratory, and a clear record of the informed consent discussion
- Document: purpose, possible results (positive / negative / VUS), limitations, possibility of secondary findings, implications for relatives, GINA discussion and its limits, cost/insurance, alternatives including declining, and that consent was obtained, declined, or deferred
- Example: "Informed consent obtained for targeted BRCA1 single-site analysis. Discussed possible results including pathogenic, negative, and uncertain; limitations; GINA protections and its exclusion of life, disability, and long-term care insurance; cost; and the voluntary nature of testing. Patient's questions answered; written consent signed."
Results Disclosure Plan:
- How and when results will be returned and by whom
- Example: "Results expected in 2 to 3 weeks; will be disclosed at a scheduled follow-up visit (in person or telehealth per patient preference)."
Surveillance and Risk-Reduction Recommendations:
- Condition-specific screening and risk-reducing options, contingent on results
- Example: "If a pathogenic variant is confirmed, recommend enhanced surveillance including annual breast MRI alternating with mammography, and discussion of risk-reducing salpingo-oophorectomy after childbearing is complete."
Cascade Testing / Family Plan:
- Recommendations for testing at-risk relatives and how to facilitate it
- Example: "If positive, recommend cascade testing for first-degree relatives; provide a family letter the patient can share with relatives and their providers."
Reproductive Options (when relevant):
- Prenatal diagnosis, preimplantation genetic testing, donor options, and counseling
- Example: "Discussed reproductive options for future pregnancies, including preimplantation genetic testing (PGT-M) and prenatal diagnosis, should the patient be a carrier."
Anticipatory Guidance and Patient Education:
- Plain-language summary of what the result will mean and educational materials provided
- Example: "Provided written summary and reputable patient resources (FORCE, NSGC) on HBOC syndrome and surveillance."
Referrals:
- Specialists, support organizations, or psychological services
- Example: "Referral to high-risk breast clinic and to a breast surgeon for surgical risk-reduction discussion if results are positive."
Documentation, Billing, and Follow-Up:
- Total face-to-face time for time-based coding, medical necessity, and follow-up plan
- Example: "Total face-to-face counseling time: 50 minutes. Follow-up visit scheduled for results disclosure. Billing codes to be confirmed and completed by the documenting clinician."

Example of a Plan Section for Genetic Counseling

Plan

GENETIC TESTING AND INFORMED CONSENT:

Targeted single-site analysis for the familial BRCA1 c.5266dupC variant ordered through the reference laboratory. Informed consent obtained and documented. The discussion covered: the purpose of the test; possible results (pathogenic, true negative for the familial variant, or uncertain); limitations and residual risk; the possibility that the result affects biological relatives; psychological implications; cost and insurance coverage; and the voluntary nature of testing including the option to decline. The Genetic Information Nondiscrimination Act (GINA) was reviewed, including its protection for health insurance and employment and its exclusion of life, disability, and long-term care insurance. The patient's questions were answered and written informed consent was signed.

RESULTS DISCLOSURE:

Results are expected in approximately 2 to 3 weeks and will be disclosed at a scheduled follow-up visit. The patient elected an in-person disclosure visit.

SURVEILLANCE AND RISK REDUCTION (contingent on results):

If the familial pathogenic variant is confirmed, recommend enhanced breast surveillance with annual breast MRI alternating with mammography beginning per guideline-based timing, clinical breast exams, and a discussion of risk-reducing salpingo-oophorectomy after completion of childbearing. These recommendations will be finalized with the high-risk clinic.

CASCADE TESTING AND FAMILY PLAN:

If the result is positive, cascade testing will be recommended for first-degree relatives. A family letter summarizing the variant and testing options will be provided for the patient to share with relatives and their healthcare providers. Predictive testing for her minor children will be deferred until they reach an age of consent, given the adult-onset nature of the condition.

REPRODUCTIVE OPTIONS:

Reproductive options for any future pregnancy were discussed, including preimplantation genetic testing for the familial variant (PGT-M) and prenatal diagnosis.

PATIENT EDUCATION AND REFERRALS:

Provided a written visit summary and reputable patient resources on hereditary breast and ovarian cancer. Referral placed to the high-risk breast clinic; surgical consultation to be arranged if results are positive.

FOLLOW-UP AND DOCUMENTATION:

Total face-to-face counseling time: 50 minutes. Follow-up visit scheduled for results disclosure and care planning. Billing codes to be confirmed and completed by the documenting clinician based on the services rendered.

AI-Assisted Documentation for Genetic Counseling

AI-powered documentation tools can substantially reduce the documentation burden of long, narrative genetic counseling encounters while preserving the structure these notes require. Genetic counseling sessions are lengthy and information-dense, which makes them well suited to ambient capture, but the precision demands of variant data require careful human review.

How AI Can Help with Genetic Counseling Documentation

Narrative pedigree capture: AI can transcribe a spoken family-history narrative into a structured pedigree summary
Consent discussion capture: AI can document the elements of the informed consent conversation as they are discussed
Counseling and psychosocial notes: AI captures the lengthy educational and supportive components efficiently
Efficiency: Reduces documentation time so counselors can spend more time with families

Genetic-Counseling-Specific AI Considerations

What AI captures well:

Reason for referral and patient goals
Family-history narratives and pedigree summaries
Informed consent discussion elements
Psychosocial assessment and counseling content
Surveillance recommendations and anticipatory guidance

What requires careful review:

Gene names and HGVS variant nomenclature (transcribe from the laboratory report, never from memory)
ACMG classification (Pathogenic / Likely Pathogenic / VUS / Likely Benign / Benign)
Zygosity and laboratory methodology
Numeric recurrence and carrier risk figures
Ages at diagnosis and which family-history items are confirmed versus reported

Tips for Using AI with Genetic Counseling Documentation

State gene and variant precisely: "BRCA1, c.5266dupC, heterozygous, classified pathogenic" rather than "the BRCA mutation"
Verbalize risk figures clearly: "Fifty percent recurrence risk per pregnancy" rather than "high risk"
Document consent elements explicitly: "We discussed possible results, limitations, implications for relatives, and GINA, and the patient consented"
Flag confirmed versus reported history: "The sister's result is confirmed by laboratory report; the aunt's diagnosis is patient-reported"
Always verify variant data against the official laboratory report before signing any AI-generated note

For more details, see our complete AI-Assisted Documentation Guide.

Free Genetic Counseling SOAP Note Template

Speed up your documentation with our comprehensive genetic counseling SOAP note template. This template includes all essential elements for risk assessment, pedigree documentation, informed consent, results disclosure, and family-centered planning.

SOAP Note Template - Genetic Counseling

SUBJECTIVE:

- Reason for referral: [Referring provider and reason]

- Patient's understanding and goals: [What patient knows and expects]

- Personal medical history: [Diagnoses with age at diagnosis, prior genetic testing]

- Family history (pedigree narrative):

- First-degree relatives: [Parents, siblings, children - ages, status, diagnoses]

- Second-degree relatives: [Grandparents, aunts, uncles - relevant diagnoses, ages]

- Deceased relatives: [Cause and age of death]

- Consanguinity: [Present/Absent/Unknown]

- Ancestry/ethnicity: [Relevant to carrier frequency, founder mutations]

- Reproductive history: [Gravida/para, losses, affected pregnancies, current pregnancy status]

- Information source: [Who reported; what was confirmed by records]

- Psychosocial history: [Emotional state, coping, support, decisional context]

OBJECTIVE:

- Pedigree: [Three-generation pedigree; inheritance pattern suggested]

- Physical/dysmorphology exam (if performed): [Measured findings only]

- Prior genetic test results (from laboratory report):

- Gene: [ ] Variant (HGVS): [ ] Zygosity: [ ] Classification: [P/LP/VUS/LB/B] Lab: [ ]

- Current/ordered testing: [Test, methodology, status]

- Risk quantification data: [Empiric/calculated risk and source; risk model applied]

- Records reviewed: [Pathology, prior reports, imaging]

ASSESSMENT:

- Risk assessment / clinical impression: [Formulation of risk and likely etiology]

- Inheritance pattern and recurrence risk: [Model and numeric risk with basis]

- Differential / alternative explanations: [If relevant]

- Variant interpretation: [ACMG classification and clinical meaning, if resulted]

- Psychosocial assessment: [Coping, risk perception, decisional readiness]

- Family/reproductive implications: [At-risk relatives, reproductive impact]

PLAN:

1. Genetic testing and informed consent: [Test ordered + consent elements: purpose, possible results, limitations, secondary findings, relative implications, GINA discussion, cost, alternatives, consent obtained/declined/deferred]

2. Results disclosure plan: [How and when results returned]

3. Surveillance / risk-reduction recommendations: [Condition-specific, contingent on results]

4. Cascade testing / family plan: [At-risk relatives, family letter]

5. Reproductive options: [PGT, prenatal diagnosis, donor options, if relevant]

6. Anticipatory guidance and patient education: [Plain-language summary, resources]

7. Referrals: [Specialists, support organizations, psychology]

8. Follow-up and documentation: [Total face-to-face time, medical necessity, follow-up; billing codes to be confirmed by clinician]

More Template Resources

Free SOAP Note Templates - Download templates for all specialties
SOAP Note Template Hub - Browse all available templates

Frequently Asked Questions

Document the pedigree systematically: include at least three generations (proband, parents, grandparents, siblings, and offspring), record ages and current health status of each individual, note the cause and age of death for deceased relatives, and capture relevant diagnoses with the age at diagnosis. Document consanguinity, ethnicity or ancestry (relevant for founder mutations and carrier frequencies), and any reproductive history including miscarriages, stillbirths, and pregnancy terminations. Reference standardized pedigree nomenclature (Bennett et al. NSGC recommendations), note who provided the information, and clearly flag any portions reported as uncertain or unconfirmed by medical records.

Informed consent documentation is the single most important element of a genetic counseling note. Document that you discussed: the purpose of the test and what it can and cannot determine, the possible results (positive, negative, variant of uncertain significance), the limitations and residual risk, the possibility of incidental or secondary findings, implications for biological relatives, psychological impact, cost and insurance coverage, alternatives to testing including declining, and the voluntary nature of testing. Document the discussion of the Genetic Information Nondiscrimination Act (GINA) and its limitations (GINA does not cover life, disability, or long-term care insurance). Record that the patient's questions were answered and that consent was obtained, declined, or deferred.

Report results using the ACMG/AMP five-tier classification: Pathogenic, Likely Pathogenic, Variant of Uncertain Significance (VUS), Likely Benign, and Benign. Document the gene, the specific variant nomenclature (HGVS, for example c.5266dupC), the zygosity, the classification reported by the laboratory, and the testing laboratory and methodology. For a VUS, document explicitly that clinical decisions should not be based on a VUS and that reclassification may occur over time. Always document results from the official laboratory report and never paraphrase a variant or its classification from memory.

Document the inheritance pattern relevant to the condition (autosomal dominant, autosomal recessive, X-linked, mitochondrial, multifactorial), the calculated or empiric recurrence risk with the basis for the figure, and any Bayesian or carrier-frequency adjustments applied. State numeric risks clearly (for example, '50% recurrence risk per pregnancy for an autosomal dominant condition with a confirmed pathogenic variant') and document the source of population risk estimates. Distinguish between a priori risk, modified risk after testing, and residual risk if testing is negative. Record how the risk figures were communicated and the patient's understanding.

Psychosocial assessment is a core, billable component of genetic counseling, not an afterthought. Document the patient's reason for seeking counseling and their expectations, emotional state and coping resources, relevant family dynamics and support systems, prior experiences with the condition in the family, decisional readiness, and any anticipatory grief, anxiety, guilt, or reproductive concerns. Note risk-perception accuracy, cultural or religious considerations affecting decisions, and any need for psychological referral. This assessment shapes the counseling approach and supports the medical necessity of the visit.

Genetic counseling provided by a certified genetic counselor is commonly reported with CPT 96040 (medical genetics and genetic counseling services, per 30 minutes of face-to-face time), while physician-provided counseling may be billed under standard evaluation and management (E/M) codes. Document total face-to-face time when using time-based codes, the medical necessity of the encounter, and the specific counseling activities performed. Reimbursement and licensure for genetic counselors vary substantially by state and payer. Do not auto-populate billing codes from a template; the documenting clinician should confirm and complete the appropriate codes based on the actual encounter.

For results disclosure, document the date results were available, who disclosed the results and by what method (in person, telehealth, telephone), the patient's emotional and informational response, and a plain-language explanation of what the result means for the patient and at-risk relatives. For anticipatory guidance, document screening or surveillance recommendations (for example, enhanced breast MRI for a BRCA1 pathogenic variant), risk-reducing options discussed, cascade testing recommendations for relatives, reproductive options if relevant, and referrals to specialists or support organizations.

Yes. SOAPNoteAI.com provides AI-assisted documentation that understands genetic counseling terminology, pedigree narratives, inheritance patterns, and consent discussions. It is fully HIPAA-compliant with a signed Business Associate Agreement (BAA), works on iPhone and iPad for documentation between sessions, and generates structured genetic counseling notes in seconds. Because variant classifications, specific gene nomenclature, and risk figures must be exact, always verify those values against the official laboratory report before signing. The tool works for genetic counseling and any other healthcare specialty.

Medical Disclaimer: This content is for educational purposes only and should not replace professional medical judgment. Always consult current clinical guidelines and your institution's policies.